lidocaine has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Elias, PM; Feingold, KR; Gao, WN; Guy, RH; Thornfeldt, CR; Tsai, JC | 1 |
1 other study(ies) available for lidocaine and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
Article | Year |
---|---|
Metabolic approaches to enhance transdermal drug delivery. 1. Effect of lipid synthesis inhibitors.
Topics: Acetone; Administration, Cutaneous; Animals; Anticholesteremic Agents; Chemical Phenomena; Chemistry, Physical; Cholesterol; Cholesterol Esters; Fatty Acids; Fatty Acids, Monounsaturated; Fluvastatin; Furans; Hypolipidemic Agents; Indoles; Lidocaine; Male; Mice; Mice, Hairless; Permeability; Skin; Skin Absorption | 1996 |